Siste oppdatering :
19/11/2024
Antibiotika   Temocilline  
Injeksjon
Oppløsningsstabilitet Stabilitet i blandinger Faktorer som påvirker stabiliteten Kompatibilitet Administrasjonsmåte Referanser pdf
   Kjemisk struktur  

Handelsnavn   Handelsnavn     

Handelsnavn er veiledende og sammensetning av hjelpestoffer kan være forskjellig avhengig av land og produsent

Negaban Belgia, Frankrike, Luxembourg, Storbritannia
Referanser   Injeksjon   Referanser : Temocilline  
Type publikasjon
2231 Journal de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2275 Journal Craig Dyar S, Notari RE.
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Int J Pharm 1998 ; 173: 221-232.
2296 Labratorium Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3154 Journal Carryn S, Couwenbergh N, Tulkens PM
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
3255 Journal Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Ann Pharm Fr 2011 ; 69, 6 : 296-301.
3385 Journal Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
3520 Labratorium Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Labratorium Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3549 Labratorium Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Labratorium Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Labratorium Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
4470 Journal Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4634 Journal Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458

  Mentions Légales